FIBROGEN INC (FGEN) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 1009 transactions totaling $128.9M, demonstrating a bearish sentiment with -$126.3M in net insider flow. The most recent transaction on Dec 6, 2025 involved a transaction of 259 shares valued at $2.2K.
No significant insider buying has been recorded for FGEN in the recent period.
No significant insider selling has been recorded for FGEN in the recent period.
Based on recent SEC filings, insider sentiment for FGEN is bearish with an Insider Alignment Score of 1/100 and a net flow of -$126.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at FIBROGEN INC (FGEN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading FGEN stock, having executed 1009 transactions in the past 90 days. The most active insider is Thomas B. Neff (Executive), who has made 359 transactions totaling $84.2M.
Get notified when executives and directors at FGEN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 6, 2025 | Wettig Thane | Executive | Payment | 259 | $8.42 | $2.2K | |
| Dec 6, 2025 | Delucia David | Executive | Payment | 52 | $8.42 | $438 | |
| Nov 17, 2025 | Wettig Thane | Executive | Purchase | 2,700 | $9.10 | $24.6K | |
| Nov 13, 2025 | Wettig Thane | Executive | Purchase | 1,000 | $9.18 | $9.2K | |
| Sep 6, 2025 | Wettig Thane | Executive | Payment | 248 | $12.10 | $3.0K | |
| Sep 6, 2025 | Delucia David | Executive | Payment | 53 | $12.10 | $641 | |
| Jun 30, 2025 | A. Schoeneck James | Executive | Purchase | 23,567 | $5.07 | $119.5K | |
| Jun 6, 2025 | Wettig Thane | Executive | Payment | 246 | $7.83 | $1.9K | |
| Jun 6, 2025 | Delucia David | Executive | Payment | 51 | $7.83 | $399 | |
| Sep 7, 2024 | Graham Juan | Executive | Payment | 1,065 | $0.39 | $415 | |
| Sep 6, 2024 | Chung Christine | Executive | Payment | 17,395 | $0.39 | $6.8K | |
| Sep 6, 2024 | Wettig Thane | Executive | Payment | 2,363 | $0.39 | $922 | |
| Sep 6, 2024 | Graham Juan | Executive | Payment | 16,050 | $0.39 | $6.3K | |
| Aug 1, 2024 | Wettig Thane | Executive | Payment | 20,840 | $0.47 | $9.8K | |
| Jun 22, 2024 | Wettig Thane | Executive | Payment | 782 | $1.13 | $884 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 533 | $127.6M | 80.3% |
Exercise(M) | 206 | $16.3M | 10.2% |
Payment(F) | 142 | $13.8M | 8.7% |
Purchase(P) | 8 | $1.3M | 0.8% |
Award(A) | 113 | $0 | 0.0% |
Gift(G) | 7 | $0 | 0.0% |
Insider selling pressure at FIBROGEN INC has increased, with 25 insiders executing 1009 transactions across all time. Total sales of $127.6M significantly outpace purchases of $1.3M, resulting in a net outflow of $126.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.